MARATTO

review · Medicine

Nosocomial infections in sickle cell anemia patients: Prevention through multi-disciplinary approach: A review

202325 citationsOpen accessOsun State University

In plain language

Patients with sickle cell anaemia (SCA) are highly susceptible to nosocomial infections, which are infections acquired during hospitalisation. This vulnerability is due to their compromised immune systems, frequent and prolonged hospital stays, and the need for invasive medical interventions. The situation is further complicated by the rise of multidrug-resistant pathogens. Healthcare facilities currently implement various preventive measures, including infection control protocols, vaccination strategies, antimicrobial stewardship, and patient education. Recognising the seriousness of this issue and adopting comprehensive prevention methods are vital for improving the quality of care and patient outcomes in this vulnerable population. Ongoing research is essential to further reduce the burden of these infections.

Key takeaways

  • Sickle cell anaemia patients face a persistent threat of nosocomial infections.
  • Their increased susceptibility is linked to compromised immune systems, frequent hospitalisations, and invasive medical procedures.
  • The emergence of multidrug-resistant pathogens complicates the management of these infections.
  • Current preventive measures include infection control, vaccination, antimicrobial stewardship, and patient education.
  • Further research and continuous efforts are needed to reduce the burden of nosocomial infections in this patient group.

Why it matters

Preventing hospital-acquired infections is critical for improving the health and safety of sickle cell anaemia patients, who are already at high risk. Reducing these infections can lead to better treatment outcomes, shorter hospital stays, and an enhanced quality of life for affected individuals.

Commercialisation angle

This review discusses existing challenges and current preventive strategies for nosocomial infections in sickle cell anaemia patients. The abstract does not indicate an application pathway for new products, services, or technologies.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Sickle cell anemia (SCA), a hereditary blood disorder characterized by the presence of abnormal hemoglobin, poses a unique set of challenges for both patients and healthcare providers. One of the most pressing issues in the care of these individuals is the persistent threat of nosocomial infections, which are infections acquired during hospitalization. This abstract provides a concise overview of the ongoing challenge of nosocomial infections in SCA patients, highlighting the factors contributing to their vulnerability and the preventive measures in place. SCA patients face increased susceptibility to nosocomial infections due to their compromised immune systems, frequent hospitalizations, prolonged stays, and the need for invasive medical interventions. The emergence of multidrug-resistant pathogens further complicates the management of these infections. To address this challenge, healthcare facilities have implemented infection control protocols, vaccination strategies, and antimicrobial stewardship, emphasizing the importance of patient education. Recognizing the gravity of this issue and adopting comprehensive preventive measures is crucial to improving the quality of care and patient outcomes in this vulnerable population. Further research and ongoing efforts are essential to reducing the burden of nosocomial infections in SCA patients and enhancing their overall healthcare experience.

Research topics

  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Blood donation and transfusion practices

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1097/md.0000000000036462

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.